NYSE · Healthcare
HCA Healthcare, Inc. (HCA)
As-reported financials and recent SEC filings for HCA Healthcare, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$75.60B
Net income
$6.78B
Net margin
9.0%
Diluted EPS
$28.33
ROE
-244.8%
P/E (TTM)
13.3×
Market cap
$85.89B
Debt / equity
-15.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| Diluted EPS | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-05-11
View on EDGAR →SCHEDULE 13G2026-04-30
View on EDGAR →42026-04-30
View on EDGAR →42026-04-30
View on EDGAR →42026-04-30
View on EDGAR →42026-04-30
View on EDGAR →42026-04-30
View on EDGAR →42026-04-30
View on EDGAR →Go deeper on HCA
Search HCA Healthcare, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.